Envista (NVST) Evercore ISI 8th Annual HealthCONx Conference summary
Event summary combining transcript, slides, and related documents.
Evercore ISI 8th Annual HealthCONx Conference summary
3 Dec, 2025Market overview and performance
Dental market remains soft but stable, with low single-digit growth and consistent trends across segments.
Consumables show the most stability, while orthodontics and implants maintain low to mid-single-digit growth.
Diagnostics experienced a negative low single-digit trend but is modestly improving, aided by interest rate optimism.
North America is recovering, Europe is strong due to favorable rates, and China remains uncertain.
Year-to-date growth is around 5%, with strong trends expected to continue through year-end.
Spark and orthodontics business
Aligner market is globally consistent, with mid-single-digit growth and Europe outperforming North America.
Focus on full solution offerings, combining aligners, brackets, and wires, drives above-market growth.
Recent product launches include Spark On Demand, retainers, BiteSync, and StageRx, enhancing clinician experience.
Innovation and portfolio breadth support sustained growth and market share gains.
Accounting and margin dynamics
Spark's revenue deferral changes have no negative impact on future growth; remaining $15M deferral is a minor tailwind.
Margin improvement levers include global automation, design cost reduction, and leveraging fixed costs through growth.
Continued investment in sales, marketing, and R&D, especially for new market entries like Japan.
Latest events from Envista
- Double-digit core growth and margin gains in 2025 set the stage for continued momentum in 2026.NVST
Q4 20256 Feb 2026 - Targets 2%-4% core growth and 7%-10% EPS growth, driven by innovation and operational discipline.NVST
CMD 20253 Feb 2026 - Q2 loss of $1.15B on impairments; sales, margins fell, but cash flow and Q4 outlook improved.NVST
Q2 20242 Feb 2026 - Q3 2024 sales fell 5.3%, net income dropped, but full-year guidance was reaffirmed.NVST
Q3 202417 Jan 2026 - Dental market growth, innovation, and operational execution drive double-digit financial gains.NVST
44th Annual J.P. Morgan Healthcare Conference13 Jan 2026 - Stable dental market, growth investments, and China VBP shape outlook for 2025.NVST
7th Annual Evercore ISI HealthCONx Conference12 Jan 2026 - Strategic investments and stable market trends position the business for renewed growth.NVST
43rd Annual J.P. Morgan Healthcare Conference 202510 Jan 2026 - Q1 2025 core sales rose 0.2% with stable guidance and effective risk mitigation.NVST
Q1 202523 Dec 2025 - Q4 core sales rose 2% with strong cash flow and a $250M buyback, despite a net loss.NVST
Q4 202419 Dec 2025